Stem Cell Transplant Flashcards

(42 cards)

1
Q

What is stem cell transplant

A

Killing individual bone marrow by chemo and radiotherapy and replacing with another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

First bone marrow transplant date

A

1939

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

First success

A

1968

Child with combined immunodeficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Malignant heam ex

A
AML
ALL
CLL
Myeolodysplastic syndrome 
Hodgkin lymphoma 
NHLs
Myelofibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non malignant heam dx

A
Aplastic anemia 
Fanconi anemia 
Thalassemia
Sickle cell anemia 
Congenital pure red cell aplasia 
Paroxysmal hemoglobinuria
Severe combine immunodeficiency 
Wiskott Aldrich syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Malignancies requiring transplant

A

Neuroblastoma
Breast ca
Lung ca \
brain ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sources of hematopoietic

A

Marrow
Peripheral blood
Umbilical cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dose required for stable long term engraftment

A

2x10^8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phénotype of stem cells

A

CD34+

CD38-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment done in transplant to mobilize

A

G-CSF treatment
GM-CSF
IL3
TPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Conditioning Purpose of transplant

A

Eradicate underlying disease

Provide sufficient immunosuppressive for administration of graft without rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Conditioning of radiation based transplant

A

Fractionated radiation

Fractionated TBI + cyclophosphamide

Fractionated TBI + etoposide

Fractionated TBI + etoposide + cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Donor characteristics in transplant

A

Good health
Good performance status for safe collection of cells
Normal cardiac, pulmonary , hepatic and renal functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Level of hematopoietic stem cell in peripheral blood

A

Low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment done to mobilize stem cell in circulation

A

G-CSF
GM CSF
IL3
Thrombopoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name of the machine That helps collect stem cells from the blood

A

Leukophoresis machine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some non-radiation based regiments before transplant

A

Oral busulphan (16mg/kg for 4 days )
Cyclophosphamide 120mg/kg for 2 days
Etoposide + busulphan
Carmustine + etoposide + Ara C + melpphalan when lymphomas
Cisplatin + carboplatin when breast cancer or ovarian cancer

18
Q

Types of Transplantation

A

Autologous
Allogeneic
syngeneic

19
Q

What is a allogeneic bone marrow transplant

A

grafting of Bone marrow from a donor into a recipient of the same species

20
Q

Types of donor in allogenic bone marrow

A

HLA compatible sibling
Partially matched family members
Closely matched unrelated volunteer donros

21
Q

How long does it take for transplanted marrow to regenerate

22
Q

How do you protect patient from infection

A

Isolation

Broad spectrum antibiotics

23
Q

How long does it take to granulocyte to go back to 0.5x10^9

24
Q

Requirements for discharge of patient after graft

A

0.5x10^9/l count or more granulocyte

Adequate oral nutrition

25
Do patients require blood transfusion , red cell and platelets during aplasia following marrow grafting
Yes
26
Main complication of graft
``` Oral mucositis Gastroenteritis Impaired cellular immunity HSV Bacterial fungal infection Neurological disorder Cataracts Endocrine disorders Recurrent dx, malignancies ```
27
When does acute graft versus host disease manifest
About 90 days after marrow transplantation
28
Presentation of acute graft versus host disease
Skin - Mild maculopapular rash or generalized erythroderma and bullae formation with desquamation Gut- anorexia ,nausea ,vomiting ,abdominal cramping pain Liver - Hyperbilirubinemia, Transaminase and alkaline phosphatase high
29
Grades of graft versus host disease
Stage I stage II stage III stage IV
30
Stage one graft versus host disease manifestation
Maculopapular rash less than 25% body surface 34 to 51 µmol liver bilirubin diarrhea with 500 to 1000 mL per day loss or persistent nausea
31
Stage two acute graft versus host disease manifestation
Maculopapular rash 25 to 50% body surface 51 to 102 µmol liver bilirubin diarrhea 1000 to 1500 mL per day loss
32
Stage three acute graft versus host disease manifestation
Generalized erythroderma 102- 255 µmol liver bilirubin diarrhea more than 1500 mL per day
33
Stage four acute graft versus host disease manifestation
Desquamation and bullae more than 255 µmol liver bilirubin diarrhea more than 1500 mL per day pain without ileus
34
Pathogenesis of graft versus host disease
Donor T cells activated by antigen recognition on host tissue Activated T cell proliferate and differentiates and produce cytokines promoting inflammatory response tissue damage and necrosis
35
Percentage of people that will develop chronic graft versus host disease after 100 days of allogeneic bone marrow Transplant
30 to 40%
36
Signs of chronic graft versus host disease
``` Debilitating skin disease oral mucositis Dry eyes chronic liver disease Weight loss neurologic disorders susceptibility to bacterial infection Obstructive liver disease ```
37
Treatment of chronic graft versus host
``` Anti-thymocyte Globulin Glucocorticoids Irradiation Cyclophosphamide Cyclosporine Azathioprine thalidomide Prednisolone Prednisolone and azthorprine ```
38
What is autologous marrow transplant
Own patient marrow cell transplanted
39
Is there gvhd in autologous
No
40
Is pre transplant immunosupression required in autologous
No
41
Medication care of autologous
``` Thiotepa Melphalan Etoposide Cytosine arabinoside 6 thioguanine ```
42
Supportive care of autologous
``` Blood component Antibiotics Parentéral nutrition Protective isolation Growth factors ```